Properties (97)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Wyeth
gptkb:Warner-Lambert Array BioPharma Hospira Hospira (2015) Array_BioPharma_(2019) Wyeth_(2009) |
| gptkbp:advertising |
focus on innovation and access
|
| gptkbp:benefits |
comprehensive health plans
|
| gptkbp:budget |
published yearly
|
| gptkbp:CEO |
gptkb:Albert_Bourla
|
| gptkbp:clinicalTrials |
gptkb:COVID-19_vaccine
oncology drugs thousands globally immunology drugs cardiovascular drugs vaccine candidates Phase I, II, III, IV various therapeutic areas rare disease treatments neuroscience drugs worldwide sites |
| gptkbp:collaborations |
government agencies
collaborations with biotech firms |
| gptkbp:community_engagement |
healthcare_access_programs
|
| gptkbp:culturalHeritage |
workplace diversity programs
|
| gptkbp:employees |
approximately 78,500 (2020)
~78,500 (2021) |
| gptkbp:facilities |
multiple locations worldwide
|
| gptkbp:financialPerformance |
varies with market conditions
strong revenue growth |
| gptkbp:firstDeployment |
diverse and inclusive
|
| gptkbp:founded |
1849
|
| gptkbp:founder |
Charles_Pfizer
|
| gptkbp:future_plans |
improve patient outcomes
|
| gptkbp:global_presence |
over 125 countries
|
| gptkbp:globalPresence |
gptkb:Angela_Hwang
|
| gptkbp:governance |
board of directors
|
| gptkbp:headquarters |
gptkb:New_York_City
gptkb:New_York_City,_USA gptkb:Manhattan,_New_York |
| https://www.w3.org/2000/01/rdf-schema#label |
Pfizer Inc.
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:innovation |
focus on new therapies
|
| gptkbp:investmentFocus |
biotechnology companies
|
| gptkbp:leadership |
executive team
|
| gptkbp:market |
~$200 billion (2021)
leading pharmaceutical company ~ 200 billion USD (2021) |
| gptkbp:market_segment |
pharmaceuticals, vaccines, consumer healthcare
|
| gptkbp:notableFeature |
Comirnaty
Lipitor Viagra Prevnar Zoloft |
| gptkbp:partnerships |
gptkb:Moderna
gptkb:BioNTech academic institutions Sanofi (collaboration on vaccines) Amgen_(collaboration_on_drugs) Astellas_Pharma_(collaboration_on_drugs) AstraZeneca_(collaboration_on_drugs) BioNTech_(COVID-19_vaccine) Boehringer_Ingelheim_(collaboration_on_drugs) Bristol-Myers_Squibb_(collaboration_on_drugs) Eli_Lilly_(collaboration_on_drugs) GSK_(collaboration_on_vaccines) Johnson_&_Johnson_(collaboration_on_drugs) Merck_&_Co._(COVID-19_treatment) Novartis_(collaboration_on_drugs) Regeneron_(collaboration_on_drugs) Vertex_Pharmaceuticals_(collaboration_on_drugs) |
| gptkbp:patentCitation |
numerous pharmaceutical patents
|
| gptkbp:philanthropy |
gptkb:Pfizer_Foundation
|
| gptkbp:products |
medications
vaccines |
| gptkbp:regulatoryCompliance |
FDA_approvals
|
| gptkbp:research |
gptkb:Mikael_Dolsten
|
| gptkbp:research_areas |
oncology
rare diseases neuroscience vaccines cardiovascular diseases immunology oncology, immunology, rare diseases |
| gptkbp:researchAndDevelopment |
over 10 billion USD (2020)
|
| gptkbp:researchInterest |
significant funding
|
| gptkbp:respondsTo |
vaccine development
|
| gptkbp:revenue |
41.9 billion USD (2020)
|
| gptkbp:social_responsibility |
health initiatives
|
| gptkbp:stockExchange |
gptkb:New_York_Stock_Exchange
PFE |
| gptkbp:subsidiary |
gptkb:Wyeth
|
| gptkbp:supplyChain |
global distribution network
|
| gptkbp:sustainability_initiatives |
environmental responsibility
|
| gptkbp:website |
www.pfizer.com
|